ENDOVASCULAR GRAFTING OF THE THORACIC AORTA, AN EVOLVING THERAPY: TEN-YEAR EXPERIENCE IN A SINGLE CENTRE
Background: Surgical therapy for the thoracic aorta carries a high morbidity and mortality. Endovascular therapy for aneurysms and its adaptation to the thoracic aorta over the past 10 years is an exciting advance. This is a retrospective review of endovascular grafting of the thoracic aorta during...
Gespeichert in:
| Veröffentlicht in: | ANZ journal of surgery 2007-11, Vol.77 (11), p.974-980 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 980 |
|---|---|
| container_issue | 11 |
| container_start_page | 974 |
| container_title | ANZ journal of surgery |
| container_volume | 77 |
| creator | Sandroussi, Charbel Waltham, Matthew Hughes, Clifford F. May, James Harris, John P. Stephen, Michael S. White, Geoffrey H. |
| description | Background: Surgical therapy for the thoracic aorta carries a high morbidity and mortality. Endovascular therapy for aneurysms and its adaptation to the thoracic aorta over the past 10 years is an exciting advance. This is a retrospective review of endovascular grafting of the thoracic aorta during the past decade at Royal Prince Alfred Hospital and the outcomes achieved over this period.
Methods: A retrospective review of all patients at our institution who underwent endovascular grafting of the thoracic aorta between March 1995 and March 2005 was carried out. Data were analysed using Stata version 8.0 (Stata corporation, College Station, TX, USA).
Results: Sixty‐five patients underwent endovascular stent grafting of the thoracic aorta. The indications were degenerative aneurysm (31), Stanford type B dissection (23) both acute (12) and chronic (11), traumatic transection (9) and penetrating ulcer (2). There were no conversions to open repair. Twenty‐two patients required additional procedures, six of which were unplanned. The median age was 65 (range 18–85), 68% of patients were men. The median procedure time was 115 min (range 55–240 min). Mean hospital stay was 9.8 ± 7.3 days and high dependency/intensive care unit stay 1.5 ± 3.2 days. Thirty‐day mortality was 0 in 41 for elective cases (one patient (2.5%) died 37 days post‐procedure) and 12% (3 of 25) for emergency cases. Complications occurred in 20 of 41 (49%) elective cases and 14 of 24 (58%) emergency cases within the first 30 days. The most frequent major complications were neurological including paraplegia (transient 2 of 65, permanent (2 of 65)) and stroke (4 of 65). Other complications included endoleak (12 of 65), acute renal failure (1 of 65), and brachial artery false aneurysm (1 of 65). The mean length of follow up was 22.5 months (range, 1–97 months). Six patients required further endovascular procedures for persistent endoleak or ongoing perfusion of chronic dissection. Late deaths (>30 days) related to the endovascular treatment occurred in two patients (3%).
Conclusion: Endovascular grafting of the thoracic aorta is an evolution in the treatment of thoracic aortic pathology. The results of elective endovascular grafts were acceptable. Emergency procedures had a higher incidence of complications and death. Improvement in graft technology, design and deployment are required. |
| doi_str_mv | 10.1111/j.1445-2197.2007.04293.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68369640</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1556855541</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4323-ec597f4cbfa8d5455c66e6bb3793543756fe3ca072cd693e45bc15dcd3d7a7cd3</originalsourceid><addsrcrecordid>eNqNkV9r2zAUxcXYWLu2X2GIPexpdiXrnz3Yg3CV1NTYxXGzdS_ClmWWNGk6q2Hpt6-8hBb2NIG4F-7vHC7nAgAxCrF_58sQU8qCCCcijBASIaJRQsLdG3D8Mnh76DEl5Ah8cG6JEOY8Ye_BERYJwRFHx-CXKi7KuZylN7ms4LSSkzorprCcwPpS-V9WMs1SKMuqll-gLKCal_l8RPy8kte3X2GtiuBWebX6ca2qTBWpglkBJZx5LFcwVUVdqVPwrm9Wzp4d6gm4mag6vQzycpqlMg8MJREJrGGJ6Klp-ybuGGXMcG552xK_MaNEMN5bYhokItPxhFjKWoNZZzrSiUb4cgI-730fhs3vrXWPer1wxq5Wzb3dbJ3mMeEJp8iDn_4Bl5vtcO930ziJCY3imHoo3kNm2Dg32F4_DIt1MzxpjPR4Cr3UY8p6TFyPp9B_T6F3Xvrx4L9t17Z7FR6y98C3PfBnsbJP_22sZTEbO68P9vqFe7S7F30z3GkufFL6ezHVPy9mPL7iuZ6QZ1zfnKU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>198342884</pqid></control><display><type>article</type><title>ENDOVASCULAR GRAFTING OF THE THORACIC AORTA, AN EVOLVING THERAPY: TEN-YEAR EXPERIENCE IN A SINGLE CENTRE</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Sandroussi, Charbel ; Waltham, Matthew ; Hughes, Clifford F. ; May, James ; Harris, John P. ; Stephen, Michael S. ; White, Geoffrey H.</creator><creatorcontrib>Sandroussi, Charbel ; Waltham, Matthew ; Hughes, Clifford F. ; May, James ; Harris, John P. ; Stephen, Michael S. ; White, Geoffrey H.</creatorcontrib><description>Background: Surgical therapy for the thoracic aorta carries a high morbidity and mortality. Endovascular therapy for aneurysms and its adaptation to the thoracic aorta over the past 10 years is an exciting advance. This is a retrospective review of endovascular grafting of the thoracic aorta during the past decade at Royal Prince Alfred Hospital and the outcomes achieved over this period.
Methods: A retrospective review of all patients at our institution who underwent endovascular grafting of the thoracic aorta between March 1995 and March 2005 was carried out. Data were analysed using Stata version 8.0 (Stata corporation, College Station, TX, USA).
Results: Sixty‐five patients underwent endovascular stent grafting of the thoracic aorta. The indications were degenerative aneurysm (31), Stanford type B dissection (23) both acute (12) and chronic (11), traumatic transection (9) and penetrating ulcer (2). There were no conversions to open repair. Twenty‐two patients required additional procedures, six of which were unplanned. The median age was 65 (range 18–85), 68% of patients were men. The median procedure time was 115 min (range 55–240 min). Mean hospital stay was 9.8 ± 7.3 days and high dependency/intensive care unit stay 1.5 ± 3.2 days. Thirty‐day mortality was 0 in 41 for elective cases (one patient (2.5%) died 37 days post‐procedure) and 12% (3 of 25) for emergency cases. Complications occurred in 20 of 41 (49%) elective cases and 14 of 24 (58%) emergency cases within the first 30 days. The most frequent major complications were neurological including paraplegia (transient 2 of 65, permanent (2 of 65)) and stroke (4 of 65). Other complications included endoleak (12 of 65), acute renal failure (1 of 65), and brachial artery false aneurysm (1 of 65). The mean length of follow up was 22.5 months (range, 1–97 months). Six patients required further endovascular procedures for persistent endoleak or ongoing perfusion of chronic dissection. Late deaths (>30 days) related to the endovascular treatment occurred in two patients (3%).
Conclusion: Endovascular grafting of the thoracic aorta is an evolution in the treatment of thoracic aortic pathology. The results of elective endovascular grafts were acceptable. Emergency procedures had a higher incidence of complications and death. Improvement in graft technology, design and deployment are required.</description><identifier>ISSN: 1445-1433</identifier><identifier>EISSN: 1445-2197</identifier><identifier>DOI: 10.1111/j.1445-2197.2007.04293.x</identifier><identifier>PMID: 17931260</identifier><language>eng</language><publisher>Melbourne, Australia: Blackwell Publishing Asia</publisher><subject>Aortic Aneurysm, Thoracic - diagnostic imaging ; Aortic Aneurysm, Thoracic - surgery ; Aortography ; Blood Vessel Prosthesis Implantation - methods ; Clinical outcomes ; Contrast Media ; Coronary vessels ; endovascular stent grafting ; Female ; Fluoroscopy ; Humans ; Iohexol - analogs & derivatives ; Male ; Middle Aged ; Postoperative Complications ; Retrospective Studies ; Skin & tissue grafts ; Stents ; Surgical techniques ; thoracic aorta ; Tomography, X-Ray Computed ; Treatment Outcome</subject><ispartof>ANZ journal of surgery, 2007-11, Vol.77 (11), p.974-980</ispartof><rights>2007 Royal Australasian College of Surgeons</rights><rights>2007 The Authors Journal compilation</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4323-ec597f4cbfa8d5455c66e6bb3793543756fe3ca072cd693e45bc15dcd3d7a7cd3</citedby><cites>FETCH-LOGICAL-c4323-ec597f4cbfa8d5455c66e6bb3793543756fe3ca072cd693e45bc15dcd3d7a7cd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1445-2197.2007.04293.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1445-2197.2007.04293.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17931260$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sandroussi, Charbel</creatorcontrib><creatorcontrib>Waltham, Matthew</creatorcontrib><creatorcontrib>Hughes, Clifford F.</creatorcontrib><creatorcontrib>May, James</creatorcontrib><creatorcontrib>Harris, John P.</creatorcontrib><creatorcontrib>Stephen, Michael S.</creatorcontrib><creatorcontrib>White, Geoffrey H.</creatorcontrib><title>ENDOVASCULAR GRAFTING OF THE THORACIC AORTA, AN EVOLVING THERAPY: TEN-YEAR EXPERIENCE IN A SINGLE CENTRE</title><title>ANZ journal of surgery</title><addtitle>ANZ J Surg</addtitle><description>Background: Surgical therapy for the thoracic aorta carries a high morbidity and mortality. Endovascular therapy for aneurysms and its adaptation to the thoracic aorta over the past 10 years is an exciting advance. This is a retrospective review of endovascular grafting of the thoracic aorta during the past decade at Royal Prince Alfred Hospital and the outcomes achieved over this period.
Methods: A retrospective review of all patients at our institution who underwent endovascular grafting of the thoracic aorta between March 1995 and March 2005 was carried out. Data were analysed using Stata version 8.0 (Stata corporation, College Station, TX, USA).
Results: Sixty‐five patients underwent endovascular stent grafting of the thoracic aorta. The indications were degenerative aneurysm (31), Stanford type B dissection (23) both acute (12) and chronic (11), traumatic transection (9) and penetrating ulcer (2). There were no conversions to open repair. Twenty‐two patients required additional procedures, six of which were unplanned. The median age was 65 (range 18–85), 68% of patients were men. The median procedure time was 115 min (range 55–240 min). Mean hospital stay was 9.8 ± 7.3 days and high dependency/intensive care unit stay 1.5 ± 3.2 days. Thirty‐day mortality was 0 in 41 for elective cases (one patient (2.5%) died 37 days post‐procedure) and 12% (3 of 25) for emergency cases. Complications occurred in 20 of 41 (49%) elective cases and 14 of 24 (58%) emergency cases within the first 30 days. The most frequent major complications were neurological including paraplegia (transient 2 of 65, permanent (2 of 65)) and stroke (4 of 65). Other complications included endoleak (12 of 65), acute renal failure (1 of 65), and brachial artery false aneurysm (1 of 65). The mean length of follow up was 22.5 months (range, 1–97 months). Six patients required further endovascular procedures for persistent endoleak or ongoing perfusion of chronic dissection. Late deaths (>30 days) related to the endovascular treatment occurred in two patients (3%).
Conclusion: Endovascular grafting of the thoracic aorta is an evolution in the treatment of thoracic aortic pathology. The results of elective endovascular grafts were acceptable. Emergency procedures had a higher incidence of complications and death. Improvement in graft technology, design and deployment are required.</description><subject>Aortic Aneurysm, Thoracic - diagnostic imaging</subject><subject>Aortic Aneurysm, Thoracic - surgery</subject><subject>Aortography</subject><subject>Blood Vessel Prosthesis Implantation - methods</subject><subject>Clinical outcomes</subject><subject>Contrast Media</subject><subject>Coronary vessels</subject><subject>endovascular stent grafting</subject><subject>Female</subject><subject>Fluoroscopy</subject><subject>Humans</subject><subject>Iohexol - analogs & derivatives</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Postoperative Complications</subject><subject>Retrospective Studies</subject><subject>Skin & tissue grafts</subject><subject>Stents</subject><subject>Surgical techniques</subject><subject>thoracic aorta</subject><subject>Tomography, X-Ray Computed</subject><subject>Treatment Outcome</subject><issn>1445-1433</issn><issn>1445-2197</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkV9r2zAUxcXYWLu2X2GIPexpdiXrnz3Yg3CV1NTYxXGzdS_ClmWWNGk6q2Hpt6-8hBb2NIG4F-7vHC7nAgAxCrF_58sQU8qCCCcijBASIaJRQsLdG3D8Mnh76DEl5Ah8cG6JEOY8Ye_BERYJwRFHx-CXKi7KuZylN7ms4LSSkzorprCcwPpS-V9WMs1SKMuqll-gLKCal_l8RPy8kte3X2GtiuBWebX6ca2qTBWpglkBJZx5LFcwVUVdqVPwrm9Wzp4d6gm4mag6vQzycpqlMg8MJREJrGGJ6Klp-ybuGGXMcG552xK_MaNEMN5bYhokItPxhFjKWoNZZzrSiUb4cgI-730fhs3vrXWPer1wxq5Wzb3dbJ3mMeEJp8iDn_4Bl5vtcO930ziJCY3imHoo3kNm2Dg32F4_DIt1MzxpjPR4Cr3UY8p6TFyPp9B_T6F3Xvrx4L9t17Z7FR6y98C3PfBnsbJP_22sZTEbO68P9vqFe7S7F30z3GkufFL6ezHVPy9mPL7iuZ6QZ1zfnKU</recordid><startdate>200711</startdate><enddate>200711</enddate><creator>Sandroussi, Charbel</creator><creator>Waltham, Matthew</creator><creator>Hughes, Clifford F.</creator><creator>May, James</creator><creator>Harris, John P.</creator><creator>Stephen, Michael S.</creator><creator>White, Geoffrey H.</creator><general>Blackwell Publishing Asia</general><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>200711</creationdate><title>ENDOVASCULAR GRAFTING OF THE THORACIC AORTA, AN EVOLVING THERAPY: TEN-YEAR EXPERIENCE IN A SINGLE CENTRE</title><author>Sandroussi, Charbel ; Waltham, Matthew ; Hughes, Clifford F. ; May, James ; Harris, John P. ; Stephen, Michael S. ; White, Geoffrey H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4323-ec597f4cbfa8d5455c66e6bb3793543756fe3ca072cd693e45bc15dcd3d7a7cd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Aortic Aneurysm, Thoracic - diagnostic imaging</topic><topic>Aortic Aneurysm, Thoracic - surgery</topic><topic>Aortography</topic><topic>Blood Vessel Prosthesis Implantation - methods</topic><topic>Clinical outcomes</topic><topic>Contrast Media</topic><topic>Coronary vessels</topic><topic>endovascular stent grafting</topic><topic>Female</topic><topic>Fluoroscopy</topic><topic>Humans</topic><topic>Iohexol - analogs & derivatives</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Postoperative Complications</topic><topic>Retrospective Studies</topic><topic>Skin & tissue grafts</topic><topic>Stents</topic><topic>Surgical techniques</topic><topic>thoracic aorta</topic><topic>Tomography, X-Ray Computed</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sandroussi, Charbel</creatorcontrib><creatorcontrib>Waltham, Matthew</creatorcontrib><creatorcontrib>Hughes, Clifford F.</creatorcontrib><creatorcontrib>May, James</creatorcontrib><creatorcontrib>Harris, John P.</creatorcontrib><creatorcontrib>Stephen, Michael S.</creatorcontrib><creatorcontrib>White, Geoffrey H.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>ANZ journal of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sandroussi, Charbel</au><au>Waltham, Matthew</au><au>Hughes, Clifford F.</au><au>May, James</au><au>Harris, John P.</au><au>Stephen, Michael S.</au><au>White, Geoffrey H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ENDOVASCULAR GRAFTING OF THE THORACIC AORTA, AN EVOLVING THERAPY: TEN-YEAR EXPERIENCE IN A SINGLE CENTRE</atitle><jtitle>ANZ journal of surgery</jtitle><addtitle>ANZ J Surg</addtitle><date>2007-11</date><risdate>2007</risdate><volume>77</volume><issue>11</issue><spage>974</spage><epage>980</epage><pages>974-980</pages><issn>1445-1433</issn><eissn>1445-2197</eissn><abstract>Background: Surgical therapy for the thoracic aorta carries a high morbidity and mortality. Endovascular therapy for aneurysms and its adaptation to the thoracic aorta over the past 10 years is an exciting advance. This is a retrospective review of endovascular grafting of the thoracic aorta during the past decade at Royal Prince Alfred Hospital and the outcomes achieved over this period.
Methods: A retrospective review of all patients at our institution who underwent endovascular grafting of the thoracic aorta between March 1995 and March 2005 was carried out. Data were analysed using Stata version 8.0 (Stata corporation, College Station, TX, USA).
Results: Sixty‐five patients underwent endovascular stent grafting of the thoracic aorta. The indications were degenerative aneurysm (31), Stanford type B dissection (23) both acute (12) and chronic (11), traumatic transection (9) and penetrating ulcer (2). There were no conversions to open repair. Twenty‐two patients required additional procedures, six of which were unplanned. The median age was 65 (range 18–85), 68% of patients were men. The median procedure time was 115 min (range 55–240 min). Mean hospital stay was 9.8 ± 7.3 days and high dependency/intensive care unit stay 1.5 ± 3.2 days. Thirty‐day mortality was 0 in 41 for elective cases (one patient (2.5%) died 37 days post‐procedure) and 12% (3 of 25) for emergency cases. Complications occurred in 20 of 41 (49%) elective cases and 14 of 24 (58%) emergency cases within the first 30 days. The most frequent major complications were neurological including paraplegia (transient 2 of 65, permanent (2 of 65)) and stroke (4 of 65). Other complications included endoleak (12 of 65), acute renal failure (1 of 65), and brachial artery false aneurysm (1 of 65). The mean length of follow up was 22.5 months (range, 1–97 months). Six patients required further endovascular procedures for persistent endoleak or ongoing perfusion of chronic dissection. Late deaths (>30 days) related to the endovascular treatment occurred in two patients (3%).
Conclusion: Endovascular grafting of the thoracic aorta is an evolution in the treatment of thoracic aortic pathology. The results of elective endovascular grafts were acceptable. Emergency procedures had a higher incidence of complications and death. Improvement in graft technology, design and deployment are required.</abstract><cop>Melbourne, Australia</cop><pub>Blackwell Publishing Asia</pub><pmid>17931260</pmid><doi>10.1111/j.1445-2197.2007.04293.x</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1445-1433 |
| ispartof | ANZ journal of surgery, 2007-11, Vol.77 (11), p.974-980 |
| issn | 1445-1433 1445-2197 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68369640 |
| source | MEDLINE; Access via Wiley Online Library |
| subjects | Aortic Aneurysm, Thoracic - diagnostic imaging Aortic Aneurysm, Thoracic - surgery Aortography Blood Vessel Prosthesis Implantation - methods Clinical outcomes Contrast Media Coronary vessels endovascular stent grafting Female Fluoroscopy Humans Iohexol - analogs & derivatives Male Middle Aged Postoperative Complications Retrospective Studies Skin & tissue grafts Stents Surgical techniques thoracic aorta Tomography, X-Ray Computed Treatment Outcome |
| title | ENDOVASCULAR GRAFTING OF THE THORACIC AORTA, AN EVOLVING THERAPY: TEN-YEAR EXPERIENCE IN A SINGLE CENTRE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T08%3A50%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ENDOVASCULAR%20GRAFTING%20OF%20THE%20THORACIC%20AORTA,%20AN%20EVOLVING%20THERAPY:%20TEN-YEAR%20EXPERIENCE%20IN%20A%20SINGLE%20CENTRE&rft.jtitle=ANZ%20journal%20of%20surgery&rft.au=Sandroussi,%20Charbel&rft.date=2007-11&rft.volume=77&rft.issue=11&rft.spage=974&rft.epage=980&rft.pages=974-980&rft.issn=1445-1433&rft.eissn=1445-2197&rft_id=info:doi/10.1111/j.1445-2197.2007.04293.x&rft_dat=%3Cproquest_cross%3E1556855541%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=198342884&rft_id=info:pmid/17931260&rfr_iscdi=true |